Myelodysplastic syndrome and myeloproliferative neoplasms

Rami Komrokji MD and Jamile Shammo MD FASCP FACP review data from key studies in myelodysplastic syndrome and myeloproliferative neoplasms presented at the 2015 American Society of Hematology Meeting.

Share

Program Content

Activities

  • EQoL-MDS: Interim Results
    EQoL-MDS: Eltrombopag in Low, Int-1 IPSS Risk MDS
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 07, 2015

    Expires: December 05, 2016

  • PRM-151 in Myelofibrosis
    Sustained 72-Week Efficacy With PRM-151 in Myelofibrosis
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 08, 2015

    Expires: December 06, 2016

  • Luspatercept in Lower-Risk MDS
    PACE-MDS: Luspatercept Associated With Hematologic Improvement, Transfusion Independence in Lower-Risk MDS
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 08, 2015

    Expires: December 06, 2016

  • Imetelstat in RARS/RARS-T
    Telomerase Inhibition With Imetelstat in Refractory Anemia (RARS/RARS-T)
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 09, 2015

    Expires: December 07, 2016

  • COMFORT-II: Ruxolitinib in MF
    Ruxolitinib vs Best Available Therapy in Myelofibrosis: A 5-Year Follow-up of COMFORT-II
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 09, 2015

    Expires: December 07, 2016

  • PegIFN2a in ET/PV: 7-Yr Data
    Peginterferon α-2a in Essential Thrombocythemia and Polycythemia Vera: 7-Year Efficacy and Safety Data
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 10, 2015

    Expires: December 08, 2016

  • Ruxolitinib + Sonidegib in MF
    Combination Ruxolitinib + Sonidegib in Myelofibrosis
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 10, 2015

    Expires: December 08, 2016

  • PERSIST-1: Subgroup Analysis
    PERSIST-1: Reduction in Spleen Volume and Symptom Scores in MF With Pacritinib vs BAT
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 10, 2015

    Expires: December 08, 2016

  • Low-Dose HMAs in LR-MDS
    Low-Dose Hypomethylating Agents Effective, Safe in Low/Int-1 Risk MDS
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 11, 2015

    Expires: December 09, 2016

  • Ruxolitinib + Pomalidomide in MF
    MPNSG-0212: Ruxolitinib + Pomalidomide Clinically Active and Well Tolerated in MF
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 12, 2015

    Expires: December 10, 2016

  • RUX + AZA in MDS/MPN
    Ruxolitinib + 5-Azacitidine in Myelodysplastic/Myeloproliferative Neoplasms
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 12, 2015

    Expires: December 10, 2016

  • Prognostic Mutations in MDS
    IWG-PM: Prognostic Significance of MDS-Associated Somatic Gene Mutations Independent of IPSS-R
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 13, 2015

    Expires: December 11, 2016

  • Rigosertib + Azacitidine in MDS
    Rigosertib + Azacitidine in Patients With Higher-Risk MDS
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 14, 2015

    Expires: December 12, 2016

  • Pracinostat + AZA in MDS
    Addition of Pracinostat to Azacitidine in Previously Untreated MDS
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 15, 2015

    Expires: December 13, 2016

  • Downloadable Slideset
    Myelodysplastic Syndrome and Myeloproliferative Neoplasms
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 11, 2016

    Expires: January 09, 2017

  • Ruxolitinib + IFN-α2 in MPN
    Danish COMBI Trial: Addition of Ruxolitinib to Interferon-α2 Therapy in Philadelphia-Negative Chronic Myeloproliferative Neoplasms
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

Provided by

ProCE Banner

Supporters

Amgen, Inc.

Celgene

Incyte

Merck & Co., Inc.

Millennium Takeda

Seagen